NOSO-95400

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNOSO-95400
Drug Alias Namesecond generation Odilorhabdines (Nosopharm)NOSO-95400
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNosopharm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNosopharm
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A